|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
6/7/2012 10:27:40 AM
MONTREAL, June 7, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International (NYSE:VRX) (TSX: VRX) today announced that it will host an Investor Day in Florham Park, New Jersey, on Thursday, June 21, 2012 from 8:30 a.m. to 12:30 p.m. ET. J. Michael Pearson, Valeant's chairman and chief executive officer, and other members of Valeant's management team will discuss the company's strategies and opportunities in each of its business regions.A live video webcast and slide presentation of the event will be available on the company's web site at www.valeant.com. To access the webcast select "Investor Relations" and find the event listed under "Events and Presentations." Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen and view to the Internet webcast. The webcast will be archived on the company's website for future on-demand replay. About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com. (Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO) Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com SOURCE Valeant Pharmaceuticals International, Inc.
|
|
|
|
|
|
|
|
|
|
|